High-flow Conditioned Oxygen Therapy Versus Non-invasive Ventilation: Prevention of Post-extubation Failure

NCT ID: NCT01191489

Last Updated: 2014-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

1042 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-09-30

Study Completion Date

2014-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main aim is to demonstrate whether the high flow conditioned oxygen therapy reduces the reintubation rate. Post-extubation respiratory failure risk will be stratified (as the randomization). In high risk patients high flow conditioned oxygen therapy will be compared with with not conditioned non-invasive mechanical ventilation. In low risk patients comparison will be conventional oxygen therapy. Hypercapnic patients will be excluded.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-extubation Respiratory Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High Flow Conditioned Oxygen Therapy in high risk patients

Group Type EXPERIMENTAL

High Flow Conditioned Oxygen Therapy in High Risk Patients

Intervention Type DEVICE

OptiFlow system (R) with nasal cannula.

Non-invasive mechanical ventilation in High Risk Patients

Group Type ACTIVE_COMPARATOR

Non-invasive mechanical ventilation

Intervention Type DEVICE

Bilevel pressure support through a facial mask

High Flow Conditioned Oxygen Therapy in Low Risk Patients

Group Type EXPERIMENTAL

High Flow Conditioned Oxygen Therapy in High Risk Patients

Intervention Type DEVICE

OptiFlow system (R) with nasal cannula.

Conventional Oxygen Therapy in Low Risk Patients

Group Type ACTIVE_COMPARATOR

Conventional Oxygen Therapy

Intervention Type DEVICE

Conventional Oxygen Therapy with nasal cannula or Venturi facial mask.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High Flow Conditioned Oxygen Therapy in High Risk Patients

OptiFlow system (R) with nasal cannula.

Intervention Type DEVICE

Non-invasive mechanical ventilation

Bilevel pressure support through a facial mask

Intervention Type DEVICE

Conventional Oxygen Therapy

Conventional Oxygen Therapy with nasal cannula or Venturi facial mask.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Low Risk Patients:
* Any extubated patients after tolerating a spontaneous breathing trial.
* High Risk Patients:
* Any extubated patients after \>48 hours under mechanical ventilation and any of the following:
* \>65 years

* cardiac failure as the primary indication of mechanical ventilation
* COPD
* APACHE II \>12 points the extubation day
* BMI \>30
* inability to manage respiratory secretions

* 1 failed spontaneous breathing trial
* 1 comorbidity
* 7 days under mechanical ventilation

Exclusion Criteria

* \<18 years
* thacheotomized patients
* recent facial or cervical trauma/surgery
* active gastro-intestinal bleeding
* lack of cooperation and patients with any failed spontaneous breathing trial because of hypercapnia development.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Infanta Sofia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gonzalo Hernandez Martinez

Gonzalo Hernandez Martinez

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gonzalo Hernandez, MD

Role: STUDY_CHAIR

Hospital Infanta Sofia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital General de Ciudad Real

Ciudad Real, Ciudad Real, Spain

Site Status

Hospital Infanta Sofia

San Sebastián de los Reyes, Madrid, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

References

Explore related publications, articles, or registry entries linked to this study.

Hernandez G, Vaquero C, Colinas L, Cuena R, Gonzalez P, Canabal A, Sanchez S, Rodriguez ML, Villasclaras A, Fernandez R. Effect of Postextubation High-Flow Nasal Cannula vs Noninvasive Ventilation on Reintubation and Postextubation Respiratory Failure in High-Risk Patients: A Randomized Clinical Trial. JAMA. 2016 Oct 18;316(15):1565-1574. doi: 10.1001/jama.2016.14194.

Reference Type DERIVED
PMID: 27706464 (View on PubMed)

Hernandez G, Vaquero C, Gonzalez P, Subira C, Frutos-Vivar F, Rialp G, Laborda C, Colinas L, Cuena R, Fernandez R. Effect of Postextubation High-Flow Nasal Cannula vs Conventional Oxygen Therapy on Reintubation in Low-Risk Patients: A Randomized Clinical Trial. JAMA. 2016 Apr 5;315(13):1354-61. doi: 10.1001/jama.2016.2711.

Reference Type DERIVED
PMID: 26975498 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HULP-3116

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Postoperative Extubation in Hypoxemic Patients
NCT06688487 NOT_YET_RECRUITING NA